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The phosphorylation of c-Jun NH (2)-terminal protein
kinase (JNK), one of the mitogen-activated protein kinases,
was analyzed in the sciatic nerves of Lewis rats with
experimental autoimmune neuritis (EAN). Western blot
analysis showed that the expression levels of both
phosphorylated JNK1 (p-JNK1, approximately 46 kDa) and
phosphorylated JNK2 (p-JNK2, approximately 54 kDa) in
the sciatic nerves of rats with EAN increased significantly
(p< 0.05) at day 14 post-immunization (PI) and remained at
this level at days 24 and 30 PI, with a slight decrease. In EAN-
affected sciatic nerves, there was intense immunostaining for
p-JNK in the infiltrating inflammatory cells (especially ED1-
positive macrophages) and Schwann cells on days 14-24 PI,
compared with those of controls. Some macrophages with
increased p-JNK immunoreactivity was shown to be
apoptotic, while some Schwann cells remained survived in
this rat EAN model, suggesting that JNK is differentially
involved in the EAN-affected sciatic nerves. These findings
suggest that JNK phosphorylation is closely associated with
the clearance of inflammatory cells as well as the activation
of Schwann cells in the EAN affected sciatic nerves.
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The c-Jun NH (2)-terminal protein kinase (JNK), also
called the stress-activated protein kinase (SAPK), is one of
three subgroups of the mitogen-activated protein (MAP)
kinase family [2]. JNK activation plays essential roles in
organogenesis during mouse development by regulating cell
proliferation, survival, or apoptosis and in immune responses
by regulating cytokine gene expression [10]. The phospho-
rylation of JNK (p-JNK) may stimulate transcription factors
that lead to cell death [14]. JNK activation has been found to
be involved in Schwann cell apoptosis induced by serum
withdrawal and insulin-like growth factor-I, while the Bcl
family proteins rescue Schwann cells, at least in part, by
inhibition of JNK activity [3]. The events described above,
including oxidative stress, cell proliferation, and cell death/
survival, are commonly observed in animals with experimental
autoimmune neuritis (EAN), which is an animal model of
human peripheral demyelinating diseases such as Guillain-
Barré syndrome [4,6].
EAN is a T-cell-mediated autoimmune disease of the
peripheral nervous system (PNS) [5]. The clinical course of
EAN is characterized by weight loss, ascending progressive
paralysis, and spontaneous recovery [1]. It has been proposed
that inflammatory mediators produced in the affected sciatic
nerve are involved in the pathogenesis of EAN [7,15].
In our previous study, we found that extracellular signal-
regulated kinase (ERK) and p38, the member of the MAP
kinase family, is activated in EAN lesions in a Lewis rat
model [1,8], demonstrating that phosphorylated ERK (p-
ERK) [1] and phosphorylated p38 [8] are mainly localized
in some Schwann cells as well as in some ED1-positive
inflammatory cells in EAN lesions. This observation implies
that increased phosphorylation of ERK by autoimmune
stimulation is associated with host cell survival, particularly
at the late stage of PNS inflammation. Although many studies
have focused on the phosphorylation of JNK in Schwann
cells in the PNS [3], little is known about the activation of
JNK in the pathogenesis of EAN, which is involved in cell
apoptosis [11] or survival [10] depending on the stage of cell
activation.
The aim of the present study was to elucidate the patterns
of JNK phosphorylation in the sciatic nerves of Lewis rats
with EAN and to confirm the cell phenotypes that were
positive for p-JNK and that may be involved in EAN.
Materials and Methods
Animals
Lewis rats were obtained from Harlan Sparague Dawley
(USA) and bred in our animal facility. Thirty-seven female
rats aged 7~12 weeks and weighing 160~200 g were used.
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EAN induction
Active EAN was induced in the Lewis rats as previously
described [1,13]. Twenty-five rats were each injected in both
hind footpads with an emulsion containing 100 µg of SP26
(Shimadzu, Japan), which is a peptide homologous to amino
acids 53-78 of bovine myelin P2 protein, in complete Freund’s
adjuvant (CFA) (Mycobacterium tuberculosis H37Ra, 5 mg/
ml; Difco, USA) and were evaluated clinically, as previously
reported [1]. Each rat was treated with 50 ng of pertussis
toxin (Sigma, USA) at days 0 and 2 after immunization. The
progress of EAN was divided into four clinical stages: grade
1 (G.1), floppy tail; grade 2 (G.2), ataxia and inability to
spread the toes; grade 3 (G.3), paraplegia; and grade 4 (G.4),
tetraplegia or moribund condition [7]. At days 10, 14-16, 24,
and 30 post-immunization (PI), five rats were killed under
ether anesthesia, and 5 cm of the sciatic nerve was removed
bilaterally from each. Twelve control rats were immunized
with CFA only.
Tissue sampling
To study the phosphorylation of JNK in the sciatic nerves
of Lewis rats with EAN, tissues were sampled post-
immunization at days 10 (during G.1), 14-16 (during G.3),
24 (after partial recovery of hindlimb paralysis, R.1), and 30
(after recovery of hindlimb paralysis, R.0). The sciatic
nerves were obtained from CFA-immunized control rats at
each matching day (n = 3 each time point). The sciatic
nerves were removed and frozen at −70
oC for protein
analysis. Pieces of the sciatic nerve were embedded in
paraffin after fixation in 4% paraformaldehyde in phosphate-
buffered saline (PBS) at pH 7.4.
Western blot analysis
Each sciatic nerve was homogenized in lysis buffer (40
mM Tris, 120 mM NaCl, 0.1% Nonidet p-40, 2 mM Na 3VO4,
1 mM PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin) with
20 strokes in a homogenizer. The homogenates were
transferred to microtubes and centrifuged at 12,000 rpm for
20 min, after which the supernatant was harvested. The
SAPK/JNK antibody kit (PhosphoPlus; Cell Signaling,
USA) was used for the immunoblot assay. The supernatant
(containing 40 µg of protein) was loaded onto a 10% SDS-
PAGE gel and transferred onto a nitrocellulose membrane
(Bio-Rad, USA). The residual binding sites on the
membrane were blocked as previously reported [12]. The
ratios of p-JNK/total JNK in each group were compared
using a one-way ANOVA, followed by a Newman-Keuls
post-hoc test. In all cases, differences with p values less than
0.05 were considered significant.
Immunohistochemistry
Paraffin tissue sections (5 µm) of sciatic nerves from
control and EAN-affected rats were de-paraffinized and
allowed to react with rabbit polyclonal anti-p-JNK (Cell
Signaling, USA), rabbit polyclonal anti-S100 (Dako, Denmark),
or mouse monoclonal anti-rat macrophage antibodies (ED1;
Serotec, UK), with slight modifications from our previous
study [9]. The immunoreactions were visualized using
avidin-biotin peroxidase complexes (Elite kit; Vector, USA),
and the peroxidase reaction was developed using a diamino-
benzidine substrate kit (Vector, USA).
For the double staining of two antigens in the same sections,
p-JNK and macrophages, double immunofluorescence was
applied using tetramethyl rhodamine isothiocyanate (TRITC)-
labeled streptavidin (1 : 500 dilution; Sigma, USA) for p-
JNK or fluorescein isothiocyanate (FITC)-labeled goat anti-
mouse IgG (1 : 50 dilution; Sigma, USA) secondary antibody
for ED1 to co-localize in the same cell.
Double staining of apoptosis and p-JNK, ED1 and S100
-immunoreactivity
DNA fragmentation was detected by in situ nick end-
labeling, performed according to the manufacturer’s
instructions (ApopTag; Intergen, USA). The co-localization
of the TUNEL (terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling) reaction and p-JNK
immunoreactivity was examined by double-labeling in the
same section using alkaline phosphatase-labeled avidin
(Vector, USA). Co-localization of the TUNEL reaction and
either ED1 or S100-immunoreactivity was detected using
double immunofluorescent labeling in the same section. In
brief, after finishing the TUNEL reaction, which was allowed
to react with TRITC-labeled anti-digoxigenin antibody, double
immunofluorescence was applied using FITC-labeled goat
anti-mouse IgG (1 : 50 dilution; Sigma, USA) or anti-rabbit
IgG (1 : 50 dilution; Sigma, USA) secondary antibodies to
co-localize the TUNEL reaction and each protein antigen in
the same cell.
To reduce or eliminate lipofuscin autofluorescence, the
sections were washed in PBS (three times for 1 h) at RT, and
then dipped briefly in distilled H2O, and treated with 10 mM
CuSO4 in ammonium acetate buffer (50 mM CH 3COONH4,
pH 5.0) for 20 min, dipped briefly again in distilled H2O,
and returned to PBS. The double immunofluorescence-
stained specimens were examined with an FV500 laser
confocal microscope (Olympus, Japan).
Results
Clinical observation of EAN
The clinical course of EAN was shown in our previous
report [1]. In brief, Lewis rats immunized with SP26
peptides developed floppy tails (G.1) at day 10 PI and
showed progressive hindlimb paralysis (G.3) at days 14-16
PI. All of the rats subsequently recovered from hindlimb
paralysis (R.0) after 24 days PI [1]. Histological examination
detected few inflammatory cells at day 14 PI in the sciatic
nerve samples from control rats. At days 10-14 PI in theIncreased phosphorylation of JNK in experimental autoimmune neuritis 15
EAN-affected rats, many inflammatory cells were found in
the sciatic nerves. The inflammatory cells gradually
disappeared in the sciatic nerves at days 24 and 30 PI when
animals recovered from hindlimb paralysis [1].
Western blot analysis of p-JNK1/JNK2 in EAN-
affected sciatic nerves
In the Western blot analysis for p-JNK1 (approximately
46 kDa) and p-JNK2 (approximately 54 kDa) in normal
rats, two weak bands were detected in the sciatic nerve. In
EAN-affected rats, the level of p-JNK1 was significantly
increased at day 14 PI (an increase of 2.39 ± 0.76 [mean ±
S.E.] times the normal level, n = 5, p < 0.05), declined after
day 24 PI (2.23 ± 0.25, n = 5, p < 0.05), and persisted its
expression at day 30 PI (2.11 ± 0.22, n = 5, p < 0.05). With a
pattern similar to p-JNK1, the p-JNK2 level was significantly
increased at day14 PI (2.37 ± 0.28, n = 5, p < 0.05), showed
a significant increase at day 24 PI (3.04 ± 0.25, n = 5, p <
0.01), and declined after day 30 PI (2.31 ± 0.05, n = 5, p <
0.05) in the sciatic nerves of rats with EAN, as compared
with levels in normal control rats (n = 5) (Fig. 1).
Localization of p-JNK in EAN-affected rat sciatic nerves
Immunohistochemical analysis was applied to visualize
the cell phenotype for p-JNK in the sciatic nerves of normal
rats and rats with EAN. In the normal rats, p-JNK was
weakly immunostained in some vascular endothelial cells
and Schwann cells (Fig. 2A). In the sciatic nerves of rats
with EAN lesions, the immunoreactivity of p-JNK was seen
in Schwann cells and some inflammatory cells at day 24 PI.
There was intense immunostaining for p-JNK in the
infiltrating inflammatory cells (Fig. 2C, arrows) and some p-
JNK-expressing Schwann cells (Fig. 2D, point-arrows) were
also positive.
Some inflammatory cells were co-localized with ED1
(Fig. 3B, arrows), suggesting that macrophages express p-
JNK (Fig. 3A, arrows) in EAN-affected sciatic nerves at day
24 PI (Fig. 3C, arrows).
Double staining of apoptosis and p-JNK, ED1 and S100
expression in the EAN affected sciatic nerves
To match the phosphorylation of JNK to apoptosis of
Fig. 1. Western blot analysis of phosphorylated JNK (p-JNK1/2)
and JNK1/2 in the sciatic nerves of EAN-affected rats. (A) A
representative photograph of a Western blot analysis of p-JN K
(p-JNK1, molecular weight ~46 kDa; p-JNK2, molecular weigh t
~54 kDa) expression. There was intense p-JNK immunoreactio n
in EAN tissues on days 14-30 post-immunization (PI), and the
intensities of the bands declined with time after immunization.
(B) A densitometric analysis of a Western blot of the total JNK1 /
2. A moderate amount of the total JNK1/2 was detected in all
samples. Bar graphs: Black bars represent the ratio of p-JNK1 /
total JNK1 in the densitometric analysis. White bars represen t
the ratio of p-JNK2/total JNK2. The expression of p-JNK1 was
significantly increased at day 14 PI and remained at this level a t
days 24 and 30 PI. The expression of p-JNK2 was shown to
follow the same pattern as p-JNK1 at day 14 PI, it furthe r
increased at 24 PI, and then its level declined at day 30 PI. Eve n
after the recovery of hindlimb paralysis at day 30 PI, the
expression levels of both p-JNK1 and p-JNK2 were higher than
those of the normal control (n = 5 samples at each time point).
*p < 0.05, **p < 0.01, compared with the normal samples.
Fig. 2. Immunohistochemical expression of p-JNK in the sciatic
nerves of normal Lewis rats (A) and Lewis rats with experimenta l
autoimmune neuritis (EAN) (B-D). In the sciatic nerves o f
normal rats (A), there was weak p-JNK immunostaining i n
vascular endothelial cells and Schwann cells. In EAN rats at day
24 PI, p-JNK immunostaining was localized to some inflammator y
cells (C, arrows) and Schwann cell (D, point-arrows) in EAN-
affected sciatic nerves. No staining was seen in primary antisera-
omitted sections of EAN-affected sciatic nerves (B). A-D were
counterstained with hematoxylin. In A-D, the scale bars = 30 µm.16 Meejung Ahn, Taekyun Shin
inflammatory cells in EAN-affected sciatic nerves, staining
for both p-JNK and the TUNEL reaction was applied. Most
of the TUNEL-positive inflammatory cells were immuno-
positive for p-JNK in the EAN-affected sciatic nerves at day
24 PI (Fig. 4A, arrows). Some TUNEL reaction was co-
localized with ED1 in the sciatic nerves at day 24 PI (Fig.
4B, arrows) as shown in a previous study [4], suggesting
that macrophages underwent apoptosis. However, the
TUNEL reaction was not detected for the Schwann cells
with the present EAN model and immunostaining methods
(Fig. 4C).
Discussion
This study is the first to confirm that JNK is phosphorylated
in host and inflammatory cells during the course of EAN in
a Lewis rat model. Specifically, Western blot analysis
revealed that the phosphorylation of JNK was significantly
increased in the affected sciatic nerves of animals with
EAN.
In a previous study, we found that the expression of p-
JNK increased in the spinal cord following encephalomyelitis
[12]. As for the role of p-JNK in animals with EAN, we
postulate that inflammatory cells, which are ultimately
associated with cell death, preferentially express p-JNK
[2,11]. For this reason, p-JNK expression declines during
the recovery stage of EAN, which is also the stage at which
the number of inflammatory cells decline. We also showed
in the present study that Schwann cells express p-JNK after
stimulation by pro-inflammatory cytokines, as previously
reported [3]. In a previous study, Schwann cells were found
to undergo apoptosis during EAN [4]. Although we have not
found a typical TUNEL reaction on Schwann cells in EAN,
we do not exclude the possibility that some Schwann cells
were eliminated through apoptosis depending on the EAN
model used. We suggest that a majority of Schwann cells
during EAN in the present study were rescued from
apoptosis through the activation of JNK, as shown in a
previous study [3].
In our previous study, we demonstrated that the phos-
Fig. 3. Immunofluorescent co-localization of p-JNK (A) and ED1 (B) in the sciatic nerves with EAN-affected rat (day 24 PI). p-JN K
(A; red, arrows) immunoreactivity was co-localized in some ED1-positive cells (B; green, arrows) in the sciatic nerves. (C; mer ged,
arrows). In A-C, the scale bars = 30 µm.
Fig. 4. Double staining of apoptosis and p-JNK, ED1 and S100 expression in the EAN- affected sciatic nerves at day 24 PI. (A) In EAN-
affected rats, some TUNEL-positive (brown, point-arrows) inflammatory cells were positive for p-JNK (blue, arrowheads) in the s ciatic
nerves (black, arrows). (B) A few ED1-positive macrophages (green) were also TUNEL-positive (red) suggesting that those cells
underwent apoptosis, as shown by the co-localization of the two colors showing yellow (arrows). (C) Some TUNEL-reaction (red) w ere
not co-localized in S100 positive Schwann cells (green) in the sciatic nerves. In A-C, the scale bars = 30 µm.Increased phosphorylation of JNK in experimental autoimmune neuritis 17
phorylation of ERK increased in the sciatic nerves with
EAN at the early stage, and the increased phosphorylation
remained in the sciatic nerve even after the EAN rats
recovered from paralysis [1]. Therefore, if the results from
the earlier study of ERK activation [1] and the phos-
phorylation of JNK in the present study are taken into
consideration, it appears that p-JNK is involved preferentially
in the activation of inflammatory cells in the sciatic nerve
with EAN, which lead to cell death of inflammatory cells,
including ED1-positive macrophages, particularly by apoptosis
during the recovery stage of EAN. We postulated that
inflammatory cells lose p-JNK signals dynamically and gain
other signals, such as iNOS [7], to lead to apoptosis during
EAN.
When all of the information is considered, we confirmed
in the present study that the expression of the phosphorylated
form of JNK is transiently increased in the sciatic nerve
following the onset of EAN. This suggests that temporal
increase of p-JNK in inflammatory cells and Schwann cells
in animals with EAN may differentially influence cell
signaling depending on cell types, which is crucial for the
modulation of inflammation during the course of autoimmune
PNS diseases, including human Guillain-Barré syndrome
and its animal model EAN.
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